Related Experiment Videos
Interferon-gamma and interleukin-2 suppress the experimental metastasis of mouse renal adenocarcinoma
N Masumori1, T Tsukamoto, Y Kumamoto
1Department of Urology, Sapporo Medical University, School of Medicine, Japan.
Abstract:
While cytokines such as interferon-alpha (IFN-alpha), interferon-gamma (IFN-gamma) and interleukin-2 (IL-2) are partially effective in the treatment of metastatic renal cell carcinoma, these cytokines have not been investigated for their ability to suppress the development of metastasis. We investigated whether they suppressed experimental pulmonary metastasis by subline-2 of streptozotocin-induced mouse renal adenocarcinoma (MRAC-PM2). IFN-gamma (1 x 10(4) and 1 x 10(5) U/mouse) and IL-2 (1 x 10(4) and 1 x 10(5) U/mouse) suppressed the experimental pulmonary metastasis of MRAC-PM2 in a dose-dependent manner, but 1 x 10(5) IU/mouse of IFN-alpha did not. The combination of 1 x 10(5) U IFN-gamma with 1 x 10(5) U IL-2 had the most powerful inhibitory effect on pulmonary metastasis without any side-effects. In addition, the combination of 1 x 10(5) U IFN-gamma with 1 x 10(5) U IL-2 had a synergistic inhibitory effect on the growth of subcutaneous tumors. These results indicate that either IFN-gamma or IL-2, or their combination, produce a more favorable effect than IFN-alpha on the metastatic development of renal adenocarcinoma.
Insights
Interferon-gamma (IFN-gamma) and Interleukin-2 (IL-2) effectively suppressed renal adenocarcinoma metastasis in mice. Their combination showed the most potent anti-metastatic and tumor growth inhibitory effects without side effects.
Area of Science:
- Immunology
- Oncology
- Biotherapy
Background:
- Cytokines like interferon-alpha (IFN-alpha), interferon-gamma (IFN-gamma), and Interleukin-2 (IL-2) show partial efficacy in treating metastatic renal cell carcinoma.
- The potential of these cytokines to suppress metastasis development remains largely unexplored.
Purpose of the Study:
- To investigate the efficacy of IFN-alpha, IFN-gamma, and IL-2 in suppressing experimental pulmonary metastasis.
- To evaluate the combined effects of IFN-gamma and IL-2 on metastasis and tumor growth.
Main Methods:
- Utilized a mouse model of streptozotocin-induced renal adenocarcinoma (MRAC-PM2) to study experimental pulmonary metastasis.
- Administered varying doses of IFN-alpha, IFN-gamma, and IL-2, both individually and in combination.
Main Results:
- IFN-gamma and IL-2 demonstrated dose-dependent suppression of pulmonary metastasis.
- IFN-alpha (1 x 10^5 IU/mouse) did not inhibit metastasis.
- The combination of IFN-gamma and IL-2 exhibited the most significant inhibition of pulmonary metastasis and synergistic suppression of subcutaneous tumor growth, with no observed side effects.
Conclusions:
- IFN-gamma and IL-2 are effective agents against renal adenocarcinoma metastasis.
- The combination of IFN-gamma and IL-2 offers a promising therapeutic strategy for managing metastatic renal adenocarcinoma, outperforming IFN-alpha.